Mitral Valve Regurgitation Treatment Market Set to Surge with Innovative Therapies in 2025 | Top Companies - Abbott Laboratories, Medtronic, Neovasc Inc.

Market Overview:

The Global Mitral Valve Regurgitation Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/mitral-valve-regurgitation-treatment-market?sz

The Mitral Valve Regurgitation Treatment Market encompasses therapies, devices, and interventions aimed at managing mitral valve insufficiency, a condition where the heart's mitral valve fails to close properly, causing blood leakage. It includes surgical repair, valve replacement, and minimally invasive procedures, alongside medications for symptom management, targeting improved cardiac function, reduced complications, and enhanced patient outcomes globally.

Industry Recent Developments: United States

✅ October 2025: Preliminary clinical results showing improvement in cardiac function after implantation of the Epygon biomimetic mitral valve were reported in two patients, indicating promising advancements in mitral valve replacement technology.

✅ September 2025: The US Mitral Regurgitation Market valued around USD 1.5 billion, with growth driven by patient awareness, aging population, and advancements in minimally invasive treatments including surgical and non-surgical interventions.

✅ August 2025: The transcatheter mitral valve replacement (TMVR) market experienced significant growth, fueled by innovative devices and increased acceptance of less invasive treatments for severe mitral regurgitation.

Industry Recent Developments: Japan

✅ October 2025: The fourth-generation mitral transcatheter edge-to-edge repair (M-TEER) system showed favorable 1-year outcomes for treating mitral regurgitation in a real-world clinical setting.

✅ September 2025: Japan's heart valve repair products market saw growing adoption of minimally invasive and transcatheter-compatible valve repair solutions, particularly for degenerative mitral regurgitation, supporting shorter hospital stays and faster recovery.

✅ August 2025: Steady growth expected in Japan's surgical heart valve market driven by demand for mechanical, tissue, and transcatheter surgical valves, with manufacturers focusing on high-quality valve production and collaboration for advanced technologies.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/mitral-valve-regurgitation-treatment-market?sz

Regulatory / FDA approvals in 2025:

✅ Abbott Laboratories's TendyneTM Transcatheter Mitral Valve Replacement (TMVR) system: On May 27 2025 the U.S. Food & Drug Administration (FDA) approved the Tendyne system to treat patients with mitral valve disease whose mitral valves are not functioning properly due to severe mitral annular calcification (MAC) - specifically in patients for whom surgery is not suitable and repair (e.g., via edge‐to‐edge) is not feasible.

✅ Valcare Medical Inc.'s AMENDTM Trans‐Septal System: On March 13 2025 the FDA granted an Investigational Device Exemption (IDE) to initiate an Early Feasibility Study (EFS) for this trans‐catheter annuloplasty ring system targeting symptomatic moderate‐to‐severe or severe functional MR (FMR).

✅ Edwards Lifesciences Corporation's SAPIEN M3 system: While not yet FDA approved (U.S.) in 2025, the company announced CE‐Mark (Europe) approval in April 2025 for its transfemoral TMVR system for patients with moderate‐to‐severe or severe MR who are unsuitable for surgery or edge‐to‐edge repair. (U.S. approval anticipated in first half of 2026)

Mergers, Acquisitions, Investments & Strategic Partnerships in 2025:

✅ 4C Medical Technologies, Inc.: In March 2025 the company closed a US $175 million Series D financing round, led by Boston Scientific Corporation, to accelerate its global pivotal trial (ATLAS) of its AltaValve TMVR system in patients with moderate‐to‐severe or severe MR.

✅ Cardiac Dimensions®, Inc.: In March 2025 the company raised US $53 million (Series E) to support its pivotal U.S. EMPOWER trial of its Carillon Mitral Contour System (indirect annuloplasty) for FMR.

✅ Strategic/partnership activity: While not strictly an M&A in 2025, multiple companies (e.g., Medtronic, Philips) have announced partnerships/training/external collaborations in structural heart/mitral therapy imaging and devices.

Major Key Players:

Abbott Laboratories
Edwards Lifesciences Corporation
LivaNova PLC
Medtronic
Neovasc Inc.
NeoChord, Inc.
HVR Cardio
Cardiac Dimensions
Cardiovalve Ltd.
Peijia Medical Limited.

Segments Covered in the Mitral Valve Regurgitation Treatment Market:

By Disease Type: Degenerative Mitral Regurgitation, Functional Mitral Regurgitation.

By Treatment Type: Surgery, Mitral Transcatheter Edge-to-Edge Repair (TEER), Transcatheter Mitral Valve Replacement (TMVR), Drugs, Others.

By Sales Channel: End-User, Distribution Channel.

Regional Analysis for Mitral Valve Regurgitation Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=mitral-valve-regurgitation-treatment-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Mitral Valve Regurgitation Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Mitral Valve Regurgitation Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Mitral Valve Regurgitation Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Mitral Valve Regurgitation Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Mitral Valve Regurgitation Treatment market?

➠ Who are the global key manufacturers of the Mitral Valve Regurgitation Treatment Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Mitral Valve Regurgitation Treatment market opportunities and threats faced by the vendors in the global Mitral Valve Regurgitation Treatment Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Mitral Valve Regurgitation Treatment market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.